J0289 HCPCS code: Injection, amphotericin b liposome, 10 mg
J0289 is the HCPCS Level II code for injection, amphotericin b liposome, 10 mg. In 2024 Medicare paid an average of $19.62 per service for J0289 across 3,072 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 150 per day on DME suppliers. Medicare volume fell 6% from 2022 to 2024 (3,261 to 3,072 services). In 2024, 36 suppliers billed Medicare for J0289 (purchases), serving 39 beneficiaries; Washington, California, Texas accounted for 61% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2003-01-01 |
| Last action effective | 2003-01-01 |
Who bills J0289 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 36 |
| Referring clinicians | 48 |
| Medicare beneficiaries | 39 |
| States with claims | 7 |
| Share of services in top 3 states (Washington, California, Texas) | 61% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 30 | 33 |
| 2023 | 29 | 35 |
| 2024 | 36 | 39 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0289, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 3,261 | 18 | $27.51 | $21.97 |
| 2023 | 2,974 | 12 | $26.89 | $21.36 |
| 2024 | 3,072 | 14 | $24.63 | $19.62 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 150 | Clinical: CMS Workgroup |
| outpatient hospital claims | 115 | Prescribing Information |
| practitioner claims | 50 | Clinical: Data |
What changed for J0289
- 2003-01-01: J0289 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0289?
J0289 is the HCPCS Level II code for injection, amphotericin b liposome, 10 mg. Short descriptor: "Amphotericin b liposome inj".
How much does Medicare pay for J0289?
In 2024, the average Medicare payment was $19.62 per service (average allowed $24.63).
Does Medicare cover J0289?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J0289 can be billed per day?
150 on DME suppliers; 115 on outpatient hospital claims; 50 on practitioner claims (NCCI medically unlikely edits).
Related J02 codes
- J0200 — Injection, alatrofloxacin mesylate, 100 mg
- J0202 — Injection, alemtuzumab, 1 mg
- J0205 — Injection, alglucerase, per 10 units
- J0206 — Injection, allopurinol sodium, 1 mg
- J0207 — Injection, amifostine, 500 mg
- J0208 — Injection, sodium thiosulfate (pedmark), 100 mg
- J0209 — Injection, sodium thiosulfate (hope), 100 mg
- J0210 — Injection, methyldopate hcl, up to 250 mg
- J0211 — Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0215 — Injection, alefacept, 0.5 mg
- J0216 — Injection, alfentanil hydrochloride, 500 micrograms
- J0217 — Injection, velmanase alfa-tycv, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0289
- Watch J0289 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0289
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.